Bearishness Around Pfizer Gilead Sparks Opportunity
Wall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...
During recessions, some index funds fare better than others. This intro highlights selection criteria and defensive positioning.
25,743 articlesWall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...
As AI and data centers expand, memory demand fuels Micron's growth. This article explains why micron technology: memo...
Palantir trades at lofty multiples, but its growth engine is real. This piece weighs the high valuation against the b...
A wave of cheaper AI models is reshaping demand for hardware, boosting NVIDIA, Micron, and SanDisk as investors weigh...
XRP remains in focus as community events and institutional moves drive the latest ripple (xrp) news today. Key develo...
NVIDIA is set to report fiscal Q4 2026 results after the close on February 25, 2026. Street expectations point to a b...
The Netherlands Gambling Authority has ordered Polymarket's Dutch affiliate to cease unlicensed betting, citing local...
Public XRPL metrics show a sharp drop in activity after the XLS-81 rollout. Analysts say the move may reflect a shift...
Nvidia’s latest earnings release produced solid numbers, but traders say the real move will come from the March GTC. ...
Institutional buyers surged into Ethereum ahead of a sustained price bounce, challenging the notion that retail was t...
As 1stdibs gears up for 2025 earnings, investors crave clarity on growth, profitability, and sustainable margins. Thi...
ASML expands beyond its EUV core with a strategic foray into advanced packaging. The move comes as TSMC leads the CoW...